We found that THBS1 was lowly expressed in AML patients, which might be induced by promoter methylation, and patients with low THBS1 expression possessed shorter survivor time; furthermore, allogenic hematopoietic stem cell transplantation could conquer the bad effect mediated by THBS1 low expression. Here, THBS1 is linked to acute myeloid leukemia.